相关实验视频
Updated: Jul 18, 2025

07:23
Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
Published on: March 7, 2022
6.0K
高血压驱动的调节T细胞乱加速心肌缺血-再输血损伤
Xuan Sun1, Yuting Feng1, Chenyi Gong1
1Department of Cardiology, Nanjing Drum Tower Hospital, State Key Laboratory of Pharmaceutical Biotechnology, Medical School of Nanjing University, China (X.S., Y.F., C.G., X.B., Z.W., H.C., B.X.).
Hypertension (Dallas, Tex. : 1979)
|August 24, 2023
概括
高血压会损害调节性T细胞 (Tregs),恶化心脏病发作后的结果. 针对这些功能失调的Tregs为心肌梗塞高血压患者提供了潜在的新治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 心血管医学 心血管医学
- 病理生理学 病理生理学
背景情况:
- 高血压与急性心肌梗塞 (AMI) 后的炎症增加和更差的预后有关.
- 调节性T细胞 (Tregs) 可能在病态状态下失去功能,但它们在高血压加速的心肌缺血-再输伤中的作用尚不清楚.
研究的目的:
- 为了调查高血压是否诱导调节性T细胞 (Treg) 功能障碍.
- 为了确定Treg功能障碍是否会加剧心肌缺血-再输损伤在高血压条件下.
- 探索AMI高血压患者的潜在治疗点.
主要方法:
- 在患有心肌缺血-再输血损伤的高血压大鼠和小鼠中进行的研究.
- 流细胞计和免疫组织化学分析Treg频率和表型.
- 重建Treg实验,以评估Treg对伤害的影响.
- 在AMI患者中临床评估循环Tregs,炎症性细胞因子和心脏功能.
主要成果:
- 高血压诱导的促炎性T助手1 (Th1) 类似的Treg子集,抑制能力降低.
- 功能障碍的Tregs加剧了心肌缺血-再输血损伤.
- 鉴定出素脱乙酶6 (HDAC6) 是扰乱Tregs.的关键调节剂.
- 在高血压的AMI患者中,循环Tregs的减少与微血管阻塞的增加相关.
结论:
- 高血压诱导的Treg变化有助于AMI患者的预后不佳.
- 向功能失调的Tregs为高血压患者治疗AMI提供了一个新的治疗策略.
相关概念视频
Myocarditis I: Introduction
9
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
9
T Cell Types and Functions
1.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.1K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
463
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
463

